Medical imaging provides a non-invasive method to visualize the internal structure of a patient. Visualization methods can be used to screen for and diagnose cancer and other maladies in a patient. For example, early screening can detect lesions within a breast that might be cancerous so that treatment can take place at an early stage in the disease.
Mammography is a form of medical imaging that utilizes x-ray radiation to visualize breast tissue. These techniques are often used to screen patients for potentially cancerous lesions and other abnormalities. Traditional mammograms involve acquiring two-dimensional (2D) images of the breast from various angles. A craniocaudal (CC) image is one of the standard image types captured with x-ray radiation. The CC image is a visualization of the breast from above (e.g., view from top of breast). Another standard image type is the mediolateral-oblique (MLO) image that images the breast from the side at an angle. Generally, MLO images are captured at an angle or at angles of forty to sixty degrees. The review and consideration of information in the CC images and in the MLO images together can increase the diagnostic power of breast imaging. Tomosynthesis is another method of taking mammograms, where a plurality of images are acquired. Each image is acquired at a respective thickness and the images are taken at a multitude of angles.
It is against this background that the present disclosure is made.
In one aspect, the present disclosure relates to a method of correlating regions of interest (ROIs) in an image pair including a cranial-caudal (CC) image and a medial-lateral-oblique (MLO) image, the method including: receiving, by an ensemble matching machine learning (ML) model, data from a similarity matching ML model, the data from the similarity matching ML model including at least a matched pair of ROIs and a first confidence level indicator associated with the matched pair of ROIs; receiving, by the ensemble matching ML model, data from a geo-matching (GM) model, the data from the GM model including at least the matched pair of ROIs and a second confidence level indicator; determining, by the ensemble matching ML model, a joint probability of correlation based on evaluation of each of the first and second confidence level by the ensemble matching ML model, wherein the joint probability of correlation provides a probability that the ROI in the CC image correlates to the corresponding ROI in the MLO image and vice versa; and providing the joint probability of correlation to an output device. In an example, the method further includes receiving data associated with training CC-MLO image pairs; and training the ensemble matching ML model with the data associated with the training CC-MLO image pairs.
In another example of the above aspect, the method further includes determining, by the ensemble matching ML model, a third confidence level indicator based on evaluation of each of the first and second confidence level and the joint probability of correlation, wherein the third confidence level indicator is a likelihood of reliability associated with the joint probability of correlation. In another example, the joint probability is a probability that the similarity correlation and the GM correlation properly correlated the CC-ROI and the MLO-ROI. In still another example, providing the joint probability of correlation to an output device comprises a numerical value associated with the joint probability of correlation.
In another example, each image of the matched lesion pair is a whole breast image. In yet another example, each image of the matched lesion pair contains only the ROI for each of the CC image and the MLO image. In still another example, providing the joint probability of correlation to an output device comprises a numerical display. In another example of the above aspect, providing the joint probability of correlation to an output device includes: receiving a selection of the CC-ROI; and presenting, in response to receiving the selection of the CC-ROI, the MLO-ROI. In a further example, the method further includes determining, in response to receiving the selection of the CC-ROI, that the joint probably of correlation exceeds a predetermined threshold; and presenting, in response to determining that the joint probability of correlation exceeds a predetermined threshold, the MLO-ROI.
In another example of the above aspect, the matched pair of ROIs includes a similarity correlation between a CC-ROI in a CC-image and a MLO-ROI in a MLO image, wherein the first confidence level indicator is a probability associated with the correlation between the CC-ROI and the MLO-ROI. In another example, the second confidence level indicator is a probability associated with a GM correlation between the CC-ROI and the MLO-ROI. In still another example, the method further includes displaying, on the output display, a pair of symbols, wherein each symbol of the pair of symbols marks a ROI of the matched pair of ROIs. In another example, the data from the GM model comprises location data for each ROI of the matched pair of ROIs. In a further example, the second confidence level indicator indicates a probability that a first location of a first ROI of the matched pair of ROIs and a second location of a second ROI of the matched pair of ROIS are a same location. In a still further example, each of the CC image and the MLO image depicts a breast and the GM model logically divides the breast into quadrants.
In another example of the above aspect, the data from the similarity model comprises characteristics data for each ROI of the matched pair of ROIs. In another example, the first confidence level indicator indicates a degree of similarity between a first set of characteristics associated with a first ROI of the matched pair of ROI and a second set of characteristics associated with a second ROI of the matched pair of ROIs. In a further example, the characteristics data includes one or more of a size, a shape, one or more margins, a location, a density, one or more colors, an orientation, a texture, a pattern, and a depth.
In another aspect, the present disclosure relates to a system for ensemble matching a cranial-caudal (CC) and a medial-lateral-oblique (MLO) image including: at least one processor in communication with at least one memory; an ensemble matching module that executes on the at least one processor and during operation is configured to: receive, from a similarity matching model, a matched CC-MLO image pair and a similarity confidence level indicator associated with the matched CC-MLO image pair; receive, from a geometric matching (GM) model, the matched CC-MLO image pair and a GM confidence level indicator associated with the matched CC-MLO image pair; apply an ensemble matching model to determine an ensemble confidence level based on an ensemble machine learning (ML) algorithm trained on a plurality of matched CC-MLO pairs; associate the ensemble confidence level with the matched CC-MLO image pair; and output the ensemble confidence level with the matched CC-MLO image pair. In an example of this aspect, the system further includes an image acquisition module.
In another example of the above aspect, the matched CC-MLO image pair comprises a first region of interest (ROI) identified in the CC image and a second ROI identified in the MLO image, wherein either of the similarity ML model or the GM model assigns a correlation to the first ROI and the second ROI. In a further example, the ensemble matching module further receives, from the GM model, location data associated with the correlation between the first ROI and the second ROI. In another further example, the ensemble matching module further receives, from the similarity ML model, shape data associated with the correlation between the first ROI and the second ROI. In a still further example, the ensemble matching module further receives, from the similarity ML model, margin data associated with the correlation between the first ROI and the second ROI. In a yet further example, the similarity matching model determines the matched CC-MLO image pair by: identifying a CC region of interest (ROI) in a CC-image received from an image acquisition module; searching an MLO image received from the image acquisition module for a MLO-ROI, wherein the MLO image includes plurality of regions and the similarity matching model review each region of the plurality of regions; determining at least one similarity characteristic of each of the CC-ROI and the MLO-ROI; and correlating the CC-ROI and the MLO-ROI based on the at least one similarity characteristic.
The present disclosure is directed to systems and methods for locating lesions within breast tissue using an imaging device. In particular, a computing system utilizes machine learning (ML) models or artificial intelligence (AI) models to navigate to a first lesion in an image of a first image type, to navigate to a second lesion in an image of a second image type, and to correlate the first lesion and the second lesion. In correlating the first lesion and the second lesion, the computing system determines that the first lesion and the second lesion are the same object within the tissue of a breast. In one embodiment, the first image type is a cranial-caudal (CC) image and the second image type is a mediolateral oblique (MLO) image. As discussed herein, an image type refers to a perspective view from which an image is taken in addition to other features, e.g., a modality with which an image is taken. The term “lesion” refers to any object of interest, such as a mass, one or more calcifications, and other suspicious areas.
In examples, systems and method embodying the present disclosure identify a first region of interest (ROI) in an image of a first image type, identify a second ROI in an image of a second image type, and correlate the first ROI to the second ROI. An ROI may contain one or more lesions. The image of the first image type may include multiple lesions. Similarly, the image of the second image type may include multiple lesions. While examples discussed in greater detail herein are primarily directed to mammograms, it will be understood by those of skill in the art that the principles of the present disclosure are applicable to other forms of breast imaging, such as tomosynthesis, ultrasound, and magnetic resonance imaging, as well as to the use of medical imaging on other structures of the body.
Generally, a computing system operates to correlate a first lesion in an image of a first image type and a second lesion in an image of a second image type, and to provide a confidence level indicator. A correlation is a determination by the system that the first and second lesion each represent a same object within the breast. The confidence level indicator indicates a level of confidence in the correlation between the first lesion and the second lesion. The confidence level indicator represents a likelihood that the determination that the first and second lesion represent a same object within the breast was reliably determined. The computing system uses one or more ML models to analyze the image of the first image type and the image of the second image type to determine if the first lesion in the image of the first image type correlates with the second lesion in the image of the second image type. The confidence level indicator may also be generally understood as a confidence score.
In an example implementation, a confidence level indicator is presented on a display. The confidence level indicator is provided to a radiologist to aid the radiologist in determining whether the first lesion in the first image type is correlated with the second lesion of the second image type. When the system determines that the first lesion in the first image type is correlated with the second lesion in the second image type, this indicates that the first and second lesion are different views of the same object within the breast of a patient. In some examples, one or more of a similarity matching ML model, a geo-matching ML model, and an ensemble matching ML model is used.
The x-ray imaging system 104 operates to take images of breast tissue using x-ray radiation. The x-ray imaging system 104 includes an x-ray imaging device 124 and the x-ray computing device 112 in communication with the x-ray imaging device 124. The x-ray imaging device 124 is described in further detail in relation to
A radiologist R operates the x-ray computing device 112 to capture x-ray images of the breast of a patient (P) using the x-ray imaging device 124. The x-ray images typically including CC and MLO images for each breast (LMLO, RMLO and RCC, LCC) as well as others. The x-ray images may be taken as part of a routine health screening or as part of a diagnostic examination.
For each image type (CC, MLO, etc.) the images may be acquired as a plurality of projections (Tp) at different angles and thicknesses. The plurality of image may be processed or reconstructed to produce a plurality of reconstructed images or slices (Tr). The plurality of Tr images may be synthesized into a single synthesized image (Ms) showing the most relevant clinical information and ROI locations. Each of the pixels in the synthesized image Ms may be mapped to a Tr image or slice. Each of the CC image and the MLO image may be one or more tomosynthesis image slices or Tr images. In embodiments, one or more of the CC image and the MLO image may be a Tp projection image.
In embodiments, each of Ms, Tr, and Tp images may be stored in the data store and can be retrieved by a radiologist for review. The images are then presented to a radiologist R who reidentifies one or more lesions in the patient P's breast that may require additional analysis to determine if the lesions are potentially cancerous and require a biopsy.
The computing system 102 operates to process and store information received from the x-ray imaging system 104. In the example of
A radiologist R will typically review a plurality of CC tomosynthesis images and a plurality of MLO tomosynthesis images for each breast. Particularly, the radiologist will visually review the plurality of images to locate a region of interest in one of the CC images and try to find a similar region in one of the corresponding MLO images. However, this process is imperfect and subject to human error because no known technology exists that can find related artifacts across different types of images.
The matching engine 106 is programmed to analyze images of different types to determine if a first lesion in a first image of a first image type is a same object as a second lesion in a second image of a second image type. Matching engine 106 includes one or more machine learning (ML) modules 116, 118, 120. Matching engine 106 represents logic or programming which operates on a processor in computer system 102, such as processing device 1402 in
In the example of
Computer system 102 uses the stored training cases in training data store 114 to train ML models 116, 118, and 120 to identify features that can be used to correlate a first and second lesion in images of the first and the second image types. In one embodiment, each ML model 116, 118, 120 is a machine learning classifier. Once trained, ML models 116, 118, and 120 can be used by matching engine 106 to correlate lesions in images of different types.
Various machine learning techniques can be utilized to generate a machine learning classifier to be used as a lesion classifier. In some examples, the machine learning models are supervised machine learning models. In other examples, one or more of the machine learning models are unsupervised machine learning models. In some examples, the machine learning models are based on an artificial neural network. In some examples, the neural network is a deep neural network (DNN). In some examples, the machine learning models are a convolutional deep neural network (CNN). In some examples, an ensemble or combination of two or more networks are utilized to generate one or more of the image classifiers. In some examples, two or more machine learning models are utilized to generate features or feature sets from the training image pairs in training data store 114.
The resulting trained machine learning classifiers, ML models 116, 118, 120, are applied by a correlation evaluator 122. Correlation evaluator 122 compares image pairs (e.g., CC-MLO image pairs) including an image of a first type (e.g., a CC image) and an image of a second type (e.g., an MLO image), and applies one or more of ML models 116, 118, 120 to the CC-MLO image pair to determine whether a first lesion in the CC image of the image pair correlates to a second lesion in the MLO image of the image pair. Correlation evaluator 122 determines a first and second lesion are correlated when the first lesion identified in the CC image is determined to be the same object as the second lesion identified in the MLO image base on ML models 116, 118, 120. Correlation evaluator 122 determines and outputs a confidence level indicator indicating a level of confidence in the correlation. In embodiments, correlation evaluator 122 is absent and the confidence level indicator is determined by matching engine 106 through the application of one or more of ML models 116, 118, 120 without correlation evaluator 122.
In one example, the confidence level indicator is a numerical value. In another example, the confidence level indicator may indicate a category of confidence such as “high,” “medium,” or “low.” In alternative examples, the confidence level indicator is provided as a percentage such as “99%,” “75%,” or “44%”. In examples, the confidence level indicator indicates a likelihood that a correlation has correctly determined that the first and second lesion are a same object.
In embodiments, the confidence level indicator includes two parts: a first confidence level indicator indicating a level of confidence in the correlation and a second confidence level indicator indicating a level of confidence in the calculation of the first confidence level indicator. For example, systems embodying the present disclosure determine a first lesion in an image of a first image type is correlated with a second lesion in an image of a second image type. The system calculates the first confidence level indicator, which is a probability that the correlation between the first and second lesion is accurate. The system also determines a second confidence level indicator, which indicates a level confidence that the first confidence level indicator was properly calculated. In this example the first confidence level indicator is an assessment of the correlation between the first and second lesions, while the second confidence level indicator is an assessment of the calculation producing the first confidence level indicator.
A graphical user interface (GUI) presented on a display of the computing system 102 operates to present information to a radiologist or other clinician. In some examples, the GUI displays a confidence level indicator overlayed on one or more image pairs being reviewed by the radiologist. For example, the GUI presents a CC image and an MLO image displayed side by side with the confidence level indicator overlaying the image pair and indicating a level of confidence that a first lesion identified in the CC image is the same object as a second lesion identified in the MLO image. In another example, a radiologist indicates a region of interest in the CC image and, in response, a corresponding MLO image having a region of interest with a highest confidence level of correlation to the region of interest in the CC image is brought up on the display. In embodiments, the corresponding MLO image has an indicator or is zoomed to the correlated region of interest.
Additionally or alternatively, the information displayed may include data such as a basis or a reason for the value of the confidence level indicator, or logic indicating why the matching engine 106 determined a particular value for the confidence level indicator. For example, coordinating location data from the geo-matching model 118 or shared shaped characteristics data from the similarity matching model 116 may be displayed. In embodiments, the confidence level indicator may be displayed on a synthesized or Ms image. Additionally, the GUI may display a letter or other symbol indicia, indicating that the first lesion in the CC image is correlated to the second lesion in the MLO image. For example, the first lesion in the CC image and the correlated second lesion in the MLO image is labeled with an “A.” If multiple regions of interest appear in the image pair, multiple letters or labels may be used. In embodiments, the letter or other symbol indicia is displayed in addition to the confidence level indicator.
The data store 108 operates to store information received from the x-ray imaging system 104 and matching engine 106. In some examples, the data store 108 is actually two or more separate data stores. For example, one data store could be a remote data store that stores images from one or more x-ray imaging systems, such as x-ray imaging system 104. Another data store could be housed locally within the computing system 102. In some examples, the data store 108 may be part of an electronic medical record (EMR) system.
The breast compression immobilizer unit 204 is supported on a first support arm 224 and the x-ray source 222 is supported on a second support arm 226. For mammography, first and second support arms 224, 226 can rotate as a unit about an axis 228 between different imaging orientations such as CC and MLO, so that the x-ray imaging system 104 can take a mammogram projection image (x-ray image) at each orientation. In operation, the image receptor 216 remains in place relative to the breast support platform 206 while an image is taken. The breast compression immobilizer unit 204 releases the breast 202 for movement of first and second support arms 224, 226 to a different imaging orientation. For tomosynthesis, the first support arm 224 stays in place, with the breast 202 immobilized and remaining in place, while at least the second support arm 226 rotates the x-ray source 222, relative to the breast compression immobilizer unit 204 and the compressed breast 202, about the axis 228. The x-ray imaging system 104 takes plural tomosynthesis projection images of the breast 202 at respective angles of the imaging beam 220 relative to the breast 202.
Concurrently and optionally, the image receptor 216 may be tilted relative to the breast support platform 206 and in sync with the rotation of the second support arm 226. The tilting can be through the same angle as the rotation of the x-ray source 222 but may also be through a different angle selected such that the imaging beam 220 remains substantially in the same position on the image receptor 216 for each of the plural images. The tilting can be about an axis 230, which can but need not be in the image plane of the image receptor 216. The tilting mechanism 218 that is coupled to the image receptor 216 can drive the image receptor 216 in a tilting motion.
When the x-ray imaging system 104 is operated, the image receptor 216 produces imaging information in response to illumination by the imaging beam 220 and supplies it to an image processor 232 for processing and generating breast x-ray images. A system control and workstation unit 238 including software controls the operation of the system and interacts with the operator to receive commands and deliver information including processed-ray images.
The x-ray imaging system 104 includes a floor mount or base 254 for supporting the x-ray imaging system 104 on a floor. The gantry 256 extends upwards from the floor mount 252 and rotatably supports both the tube head 258 and a support arm 260. The tube head 258 and support arm 260 are configured to rotate discretely from each other and may also be raised and lowered along a face 262 of the gantry so as to accommodate patients of different heights. An x-ray source, described elsewhere herein and not shown here, is disposed within the tube head 258. The support arm 260 includes a support platform 264 that includes therein an x-ray receptor and other components (not shown). A compression arm 266 extends from the support arm 260 and is configured to raise and lower linearly (relative to the support arm 260) a compression paddle 268 for compression of a patient breast during imaging procedures. Together, the tube head 258 and support arm 260 may be referred to as a C-arm.
A number of interfaces and display screens are disposed on the x-ray imaging system 104. These include a foot display screen 270, a gantry interface 272, a support arm interface 274, and a compression arm interface 276. In general, the various interfaces 272, 274, and 276 may include one or more tactile buttons, knobs, switches, as well as one or more display screens, including capacitive touch screens with graphic user interfaces (GUIs) so as to enable user interaction with and control of the x-ray imaging system 104. In examples, the interfaces 272, 274, 276 may include control functionality that may also be available on a system control and workstation, such as the x-ray computing device 112 of
In examples, the gantry interface 272 may enable functionality such as: selection of the imaging orientation, display of patient information, adjustment of the support arm elevation or support arm angles (tilt or rotation), safety features, etc. In examples, the support arm interface 274 may enable functionality such as adjustment of the support arm elevation or support arm angles (tilt or rotation), adjustment of the compression arm elevation, safety features, etc. In examples, the compression arm interface 276 may enable functionality such as adjustment of the compression arm elevation, safety features, etc. Further, one or more displays associated with the compression arm interface 276 may display more detailed information such as compression arm force applied, imaging orientation selected, patient information, support arm elevation or angle settings, etc. The foot display screen 270 may also display information such as displayed by the display(s) of the compression arm interface 276, or additional or different information, as required or desired for a particular application.
As described earlier, a CC-MLO image pair, taken, for example, by x-ray imaging system 104, is analyzed to determine a correlation between a first lesion in the CC image and a second lesion in the MLO image. The CC-MLO image pair is analyzed by a matching engine using one or more ML models. The machine learning models include one or more of a similarity matching ML model, a geo-matching ML model, and an ensemble ML matching model (e.g., ML models 116, 118, 120 in
When applying the similarity matching ML model, the matching engine compares the first and second lesions to determine a confidence level indicator that represents how similar in appearance or location the first and second lesions are to each other. The similarity matching ML model provides criteria to determine the similarity of two or more lesions based on factors or features such as shape, margin, proximity or relationship to anatomical landmarks or other notable features in the image, etc. . . . The similarity matching ML model may be a neural network and, in embodiments, is a feature-based network. The neural network may be a fully connected network. In examples, the similarity matching ML model is a deep learning neural network, such as a deep convolutional network.
When applying the geo-matching ML model, the matching engine maps the first and second lesions in each of a first image (e.g., a CC image) and a second image (e.g., a MLO image) based on one or more criteria to determine if the first lesion is a same object as the second lesion. In one embodiment, the criteria include a distance between a lesion and one or more identifiable physical or anatomical landmarks. The anatomical landmarks include, but are not limited to, the nipple, the chest wall, and the pectoral muscle. In embodiments, the criteria include a probability that a lesion is located in a particular quadrant of the image or the volume being imaged (e.g., a breast). The geo-matching ML model may be a neural network or other ML model. In embodiments the geo-matching model is a rule-based AI.
When applying the ensemble matching model, the matching engine compares correlation data received from other models in the system, such as similarity matching model 116 and geo-matching model 118, and determines and outputs a joint probability of correlation. In examples, the ensemble matching model may be a feature-based neural network. The ensemble matching model may generate features related not only to the lesions in the different image types, but features related to data received from other matching models in the system. For example, data or confidence level indicators produced by other ML models may be a feature in the ensemble matching model.
As shown in the graphic representation 608 of the breast, a target lesion 610 extends into the quadrants 0 and 3. If the vertical line 604 represents an x axis and the horizontal line 602 represents a y axis of a cartesian coordinate system, a lesion 610 has a z max 616 in quadrant 0 and a z min 618 in quadrant 3. A geo-matching ML model is applied to estimate which quadrant a first lesion in a CC image is located in, to estimate which quadrant a second lesion in an MLO image is located in, and to compare the two estimated quadrants to determine if the estimated quadrants match. The geo-matching module can used to determine a confidence level indicator (e.g., a probability) that the first and second lesions in the CC and MLO images are the same lesion. In some embodiments, a probability map for the quadrants 0, 1, 2, 3 is determined and used with the geo-matching ML model to correlate a first lesion in a CC image with a second lesion in an MLO image.
In some instances, due at least in part to factors such as the density of the breast tissue, the positioning of the breast, the compression of the breast, or any motion of the breast tissue during the compression, the similarity matching technique or the geo-matching technique may be more suitable for correlating first and second lesions in the first and second image types.
For example, due to the motion of the breast tissue, a first soft tissue lesion in a CC image may be estimated to be in one quadrant while a second soft tissue lesion in an MLO image can be estimated to be a different quadrant despite the first and second lesion in fact representing a same object in the breast. Since the soft tissue legions in the respective CC-MLO image pairs remain similar in one or more of the shape, the margins, the orientation, the density, the size, or the depth of the soft tissue lesion within the breast, despite factors such as movement during compression, the similarity matching technique can be more effective than the geo-matching technique in correlating the first and second soft tissue lesions in the CC-MLO image pairs in this example scenario.
In contrast, a geo-matching technique can be more suitable for correlating first and second lesions like those seen the example CC-MLO image pairs 800, 802, 804 shown in
Based at least on the different strengths and effectiveness between the similarity matching technique and the geo-matching technique, embodiments disclosed herein use an ensemble matching technique to correlate first and second lesions in CC and MLO image pairs (e.g., the ensemble matching ML model 120 in
Using geo-matching ML model 118, matching engine 106 determines whether one or more lesions are present in CC-MLO image pair 900, 902 outputs results data 912, including a confidence level indicator, that a first lesion present in CC image 900 is correlated to a second lesion present in MLO image 902. Geo-matching ML model 118 is used to determine the results data 912 based on features or rules learned from geo-matching model training 908.
The similarity matching ML model 116 is applied to CC-MLO image pair 900, 902 by matching engine 106. Similarity matching ML model 116 previously received similarity matching model training 910. Similarity matching model training 910 comprises training data for training the similarity matching ML model 116 and may be stored in a training data store, such as training data store 114 of
Similarity matching ML model 116 is used to determine whether one or more lesions are present in CC image 900 and MLO image 902 and outputs results data 914, including a confidence level indicator, that a first lesion in CC image 900 is correlated to a second lesion in MLO image 902. Similarity matching ML model 116 is used to determine the results data 914 based on similarity matching model training 910. In examples, matching engine 106 executes similarity matching ML model 116 on similarity matching model training 910, for example to generate a feature set, and generates the results data 914 by applying the feature set to the CC-MLO image pair 900, 902.
Matching engine 106 applies ensemble ML model 102 to results data 912 from the geo-matching ML model 118 (e.g., a geo-matching confidence level indicator) and results data 914 from the similarity matching ML model 116 (e.g., a similarity confidence level indicator). In embodiments, ensemble matching ML model 120 is also employed to analyze CC-MLO image pair 900, 902 directly.
Ensemble matching ML model 120 may be applied to CC-MLO image pair 900, 902 as output data from one or both of geo-matching ML model 118 and similarity matching ML model 116. For example, results data 912 from geo-matching ML model 118 may include the CC-MLO image pair annotated to show quadrants or other location data used to calculate the geo-matching confidence level indicator. Results data 914 from similarity matching ML model 116 may include the CC-MLO image pair annotated to show shape or margin data for the first and second lesions. Ensemble matching ML model 120 may be applied to CC-MLO image pair 900, 902 independently of either geo-matching ML model 118 and similarity matching ML model 116.
Results data 912, 914 generally includes a geo-matching confidence level from geo-matching ML model 118 and a similarity confidence level from similarity matching ML model 116. In embodiments, results data 912, 914 comprise additional data from one or both of geo-matching ML model 118 and similarity matching ML model 116. For example, geo-matching results data 912 from geo-matching ML model 118 may also include a distance between a lesion and an anatomical landmark for each of CC image 900 and MLO image 902, or may include quadrant estimations for each of a first lesion in CC image 900 and a second lesion in MLO image 902. Similarity results data 914 from similarity matching ML model 116 may include similarity data, such as shape, texture, orientation, or margin.
Matching engine 106 uses ensemble ML model 120 to evaluate the CC and MLO images 900, 902 with the results data 912, 914 from the geo-matching and similarity matching ML models 118, 116 and produces a joint probability of correlation 904 that represents the probability that the first and second lesions in the CC and MLO image pair are the same object within the breast. Joint probability of correlation 904 may be a single value representing a probability that the correlation of a first and second lesion between the CC image 900 and the MLO image 902 is a reliable correlation. In examples, joint probability of correlation 904 includes at least two elements: a correlation probability 918 that represents the likelihood that the correlation is reliable, and a correlation confidence level 920 which represents a likelihood that the probability calculation itself is reliable.
Ensemble ML model 120, prior to receiving results data 912, 914, is trained using ensemble model training 916. Ensemble model training 916 comprises training data for training the ensemble matching ML model 120 and may be stored in a training data store, such as training data store 114 of
Regardless of whether ensemble model training 916 is a same or different data set as compared to training data received by other models in the system, ensemble ML model 120 generates a unique feature set. Ensemble ML model 120 develops a feature set that includes features related to images, lesions, and other ROIs, and also includes features related to results data 912, 914, such as scoring, confidence level, location data, shape data, margin data, etc.
Ensemble ML model 116 is used by matching engine 106 to determine how reliable the correlations made using geo-matching ML model 118 and similarity matching ML model 116 are, and presents this reliability determination as a joint probability of correlation 904. Joint probability of correlation 904 may be a single output, such a numerical probability or color-coded confidence level indicator, or may have two or more parts. The example process flow 906 presents the joint probability of correlation as a correlation probability 918 and an associated correlation confidence level 920.
To consider an example case, a particular first and second lesion may be of a kind for which geo-matching is more effective, e.g., a cluster of calcifications. The ensemble matching ML model may be trained to identify when the target lesion is a calcification and to place a greater weight on data received from the geo-matching ML model in such a case. However, in this example scenario, the cluster of calcifications may be located on a boundary between two or more quadrants. The ensemble matching ML model may also be trained to reduce confidence in the geo-matching ML model is this situation where a lesion crosses over a quadrant boundary, as this prevents the lesion from being accurately estimated as being in one quadrant or the other. In this scenario, both the geo-matching ML model and similarity matching ML model may determine high likelihood of correlation, which would result in a high correlation probability. However, because confidence in the similarity matching ML model is reduced due to the type of lesion and confidence in the geo-matching ML model is reduced due to the location of the lesion on a quadrant boundary, the high correlation probability is accompanied by a low correlation confidence level.
Ensemble ML model 120 is trained to determine the joint probability of correlation 904 based on ensemble model training 916. In examples, ensemble ML model 120 executes a ML algorithm on ensemble model training 916, for example to generate a feature set, and the joint probability of correlation 904 is determined when matching engine 106 uses ensemble ML model to apply the feature set to the CC-MLO image pair 900, 902 and the results data 912, 914. In embodiments, process flow 906 may further include a correlation evaluator, such as correlation evaluator 122 of
The data from the distance determination and the quadrant determination are combined. In embodiments, geo-matching ML model is used to perform both a distance estimation to an anatomical landmark and a quadrant assignment, while in other embodiments, geo-matching ML model may be used to perform only one or the other method of evaluation, or another location- or geometry-based evaluation of a lesion's placement within a breast or other imaged volume.
In embodiments, each image of an image pair is individually evaluated as a whole using the geo-matching model. For example, each of a CC image and an MLO image in an image pair may be fully evaluated using the geo-matching ML model to identify lesions and estimate the locations of the lesions before the geo-matching ML model is used to determine whether a correlation exists between a first lesion identified in the CC image and a second lesion identified in the MLO image. One or more first lesions identified in the CC image and one or more second lesions may be identified in the MLO image. One or more correlations may be determined to exists between the first and second lesions in the CC image and the MLO image. For example, two first lesions may be identified in the CC image, first lesion (a) and first lesion (b), and two second lesions in the MLO image, second lesion (a) and second lesion (b). A first correlation may be determined to exist between first lesion (a) and second lesion (a), and a second correlation may be determined to exists between first lesion (b) and second lesion (b).
The geo-matching ML model is used to compute a confidence level indicator at block 1006. As described earlier, the confidence level indicator represents a probability that the first lesion in an image of the first image type (e.g., the CC image) is a same object as the second lesion in an image of the second image type (e.g., the MLO image). In some instances, the radiologist is interested in understanding the determination of the confidence level based on the geo-matching model alone. The confidence level indicator may be then presented to a radiologist at block 1008. In one embodiment, the confidence level indicator is displayed to the radiologist on a display device. In examples, a letter or other symbol indicia may be displayed to mark each of the first lesion in the CC image and the second lesion in the MLO image. If multiple regions of interest appear in the image pair, multiple letters or labels may be used. In embodiments, the letter or other symbol indicia is displayed without the confidence level indicator.
Next, as shown in optional block 1010, additional information is presented to the radiologist. The additional information may include, but is not limited to, an explanation as to why the matching engine derived the confidence level indictor presented or the reasoning why this CC-MLO pair has a higher (or lower) confidence level indicator. For example, measurement or other distance data and identification of the anatomical landmark used is displayed. An anatomical quadrant map may be displayed with the first or second lesion's orientation in a particular quadrant of each image type overlayed on the anatomical quadrant map. Sources of uncertainty may be identified on the display, such as indicating a lesion is lying on a quadrant boundary or indicating an inconsistency between the first lesion's relationship to a particular anatomical landmark and the second lesions relationship to the particular anatomical landmark.
The CC and MLO images are received by the matching engine at block 1000. One or more characteristics of a first lesion in the CC image and a second lesion in the MLO image are determined at block 1100 using the similarity matching ML model. The characteristics assigned to a lesion include, but are not limited to, the size, the shape, the margins, the location, the density, the color, the orientation, the texture, the pattern, or the depth within the breast.
In embodiments, each image of an image pair is individually evaluated as a whole. For example, each of a CC image and an MLO image in a pair is fully evaluated using the similarity matching ML model to identify lesions or potential lesion and fully characterize the identified lesions before the similarity matching ML model is used to determine whether a correlation exists between a first lesion in the CC image and a second lesion in the MLO image. Like the geo-matching ML model, the similarity matching ML model may be used to identify and correlate one or more lesions in the image pair.
The similarity matching ML model is used to compute a confidence level indicator at block 1006. As described earlier, the confidence level indicator represents a probability that the first lesion in an image of the first image type (e.g., the CC image) is a same lesion as the second lesion in an image of the second image type (e.g., the MLO image). In some instances, the radiologist is interested in understanding the determination of the confidence level based on the similarity matching ML model alone. The confidence level indicator may be then presented to a radiologist at block 1008. In one embodiment, the confidence level indicator is displayed to the radiologist on a display device. In examples, a letter or other symbol indicia pair may be displayed to mark each of the first lesion in the CC image and the second lesion in the MLO image. If multiple regions of interest appear in the image pair, multiple letters or labels may be used. In embodiments, the letter or other symbol indicia is displayed without the confidence level indicator.
Next, as shown in optional block 1010, additional information is presented to the radiologist. The additional information may include, but is not limited to, an explanation as to why the matching engine derived the confidence level indictor presented or the reasoning why a particular CC-MLO pair has a higher (or lower) confidence level indicator. For example, shape, texture, orientation, or other characteristic data is displayed. One or more overlays may be presented over each of the first and second lesions, indicating, for example, shape or margin boundaries and indicating similarities or differences between the characteristics of the first and second lesion.
The CC and MLO images are received at block 1000. At block 1200, the confidence level indicator produced using the geo-matching ML model is received. In some cases, the distances between each of the first and second lesions and one or more anatomical landmarks for each of the CC and the MLO images, or an estimated quadrant for each of the first and second lesions in the CC and the MLO images, or other additional data are also received. At block 1202, the confidence level indicator produced using the similarity matching ML model is received. In embodiments, one or more characteristics of the first and second lesions in the CC and the MLO images, or other additional data are also received.
The ensemble matching ML model is used to analyze the CC and the MLO images, the confidence level indicators provided from each of the geo-matching ML model and the similarity matching ML model, and, in some embodiments, the any additional data received from one or both of the geo-matching and similarity matching ML models. Based on the analysis using the ensemble matching ML model, the matching engine generates a joint probability of correlation at 1204.
Part of the analysis may include emphasizing the data received from one type of model over another model or associating a greater or lesser weight with data received from a particular model. For example, based on a type of lesion the first and second lesions are identified to be (e.g., soft tissue lesions or clusters of calcifications), the ensemble matching ML model may determine, based on its training or previous analyses, that the data from either of the similarity matching ML model and the geo-matching ML model is more accurate in predicting the probability that the target lesions correlate to each other (and vice versa).
Additionally or alternatively, if the confidence level indicator produced by one model is relatively high while the confidence level indicator received from the other model is relatively low, the ensemble matching ML model may rely on the data received from the model that provided the relatively higher confidence level indictor (or vice versa). For example, for dense breasts the similarly matching ML model may result in a relatively low confidence level indicator due to obscuration of a lesion by the density of the surrounding tissue, while the geo-matching location ML model is able to compensate for the low confidence level indicator from the similarity matching ML model by providing a relatively high confidence level indicator indicating that the CC and MLO images are matching. Such adjustments may be indicated to the radiologist with a joint confidence level of correlation associated with the joint probability of correlation. In embodiments, such adjustments may be opaque to the radiologist but may be reflected in a relative weight assigned to one or both of the geo-matching ML and similarity matching ML model's contribution to the joint probability.
The joint probability of correlation may be then presented to a radiologist at block 1206. In one embodiment, the joint probability of correlation is displayed to the radiologist on a display device. The joint probability of correlation may also be used to determine other outputs to a display device. For example, a threshold may be associated with the joint probability of correlation such that if a user selects a lesion or ROI in a CC image and a joint probability of correlation exceeding a predetermined threshold is associated with that lesion or ROI, the system may automatically display a MLO image with the correlated lesion or ROI.
In examples, a letter or other symbol indicia may be displayed to mark each of the first lesion in the CC image and the second lesion in the MLO image. If multiple regions of interest appear in the image pair, multiple letters or labels may be used. In embodiments, the letter or other symbol indicia is displayed without the confidence level indicator.
Next, as shown in optional block 1010, additional information is presented to the radiologist. The additional information may include, but is not limited to, any of the additional information discussed above in relation to methods 1012, 1112.
The labeled CC-MLO image pairs are input to the ensemble matching ML model at block 1302. Training data for the similarity matching ML model and for the geo-matching ML model are input to the ensemble matching ML model at block 1304. The ensemble matching ML model is trained using the human-labeled CC-MLO image pairs and the training data for the similarity and geo-matching ML models at block 1306. In embodiments, the ensemble matching ML model may generate a feature set based on the human-labeled CC-MLO image pairs and the training data for the similarity and geo-matching ML models. The trained ensemble matching ML model is then used, at block 1308, in a lesion identification and correlation system, such as the system 100 shown in
In some embodiments, the similarity matching and the geo-matching ML models are trained using known training techniques. Additionally, the human-labeled CC-MLO image pairs are also used to train the similarity matching ML model and the geo-matching ML model. Each model can be trained independent of the other models. Alternatively, the geo-matching, similarity matching, and ensemble matching ML models may be trained in one step or training process.
Other embodiments can arrange the blocks in the flowcharts shown in
In the example shown in
The computing device 1400 further includes one or more storage devices (collectively storage device 1414). The storage device 1414 is able to store software instructions and data. For example, the storage device 1414 stores the GUI shown in
The storage device 1414 is connected to the processing device 1402 through a storage controller (not shown) connected to the bus 1422. The storage device 1414 and its associated computer-readable storage media provide non-volatile, non-transitory data storage for the computing device 1400. Although the description of computer-readable storage media contained herein refers to a storage device, such as a hard disk or solid-state disk, it should be appreciated by those skilled in the art that computer-readable data storage media can include any available tangible, physical device or article of manufacture from which the processing device 1402 can read data and/or instructions. In certain examples, the computer-readable storage media includes entirely non-transitory media.
Computer-readable storage media include volatile and non-volatile, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable software instructions, data structures, program modules or other data. Example types of computer-readable data storage media include, but are not limited to, RAM, ROM, EPROM, EEPROM, flash memory or other solid state memory technology, CD-ROMs, digital versatile discs (“DVDs”), other optical storage media, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and which can be accessed by the computing device 1400.
According to some examples, the computing device 1400 can operate in a networked environment using logical connections to remote network devices through a network 1452, such as a wireless network, the Internet, or another type of network. The computing device 1400 may connect to the network 1452 through a network interface unit 1404 connected to the bus 1422. It should be appreciated that the network interface unit 1404 may also be utilized to connect to other types of networks and remote computing systems.
The computing device 1400 also includes an input/output controller 1406 for receiving and processing input from a number of other devices, including a touch user interface display screen, or another type of input device. Similarly, the input/output controller 1406 may provide output to a touch user interface display screen or other type of output device.
As mentioned briefly above, the storage device 1414 and the RAM 1410 of the computing device 1400 can store software instructions and data. The software instructions include an operating system 1418 suitable for controlling the operation of the computing device 1400. The storage device 1414 and/or the RAM 1410 also store software instructions, that when executed by the processing device 1402, cause the computing device 1400 to provide the functionality discussed herein.
Illustrative examples of the systems and methods described herein are provided below. An embodiment of the system or method described herein may include any one or more, and any combination of, the clauses described below.
Clause 1. A method of correlating regions of interest (ROIs) in an image pair comprising a cranial-caudal (CC) image and a medial-lateral-oblique (MLO) image, the method comprising: receiving, by an ensemble matching machine learning (ML) model, data from a similarity matching ML model, the data from the similarity matching ML model including at least a matched pair of ROIs and a first confidence level indicator associated with the matched pair of ROIs; receiving, by the ensemble matching ML model, data from a geo-matching (GM) model, the data from the GM model including at least the matched pair of ROIs and a second confidence level indicator; determining, by the ensemble matching ML model, a joint probability of correlation based on evaluation of each of the first and second confidence level by the ensemble matching ML model, wherein the joint probability of correlation provides a probability that the ROI in the CC image correlates to the corresponding ROI in the MLO image and vice versa; and providing the joint probability of correlation to an output device.
Clause 2. The method of clause 1, further comprising: receiving data associated with training CC-MLO image pairs; and training the ensemble matching ML model with the data associated with the training CC-MLO image pairs.
Clause 3. The method of clause 1 or 2, further comprising determining, by the ensemble matching ML model, a third confidence level indicator based on evaluation of each of the first and second confidence level and the joint probability of correlation, wherein the third confidence level indicator is a likelihood of reliability associated with the joint probability of correlation.
Clause 4. The method of any of clauses 1-3, wherein the joint probability is a probability that the similarity correlation and the GM correlation properly correlated the CC-ROI and the MLO-ROI.
Clause 5. The method of any of clauses 1-4, wherein providing the joint probability of correlation to an output device comprises a numerical value associated with the joint probability of correlation.
Clause 6. The method of any of clauses 1-5, wherein each image of the matched lesion pair is a whole breast image.
Clause 7. The method of any of clauses 1-6, wherein each image of the matched lesion pair contains only the ROI for each of the CC image and the MLO image.
Clause 8. The method of any of clauses 1-7, wherein providing the joint probability of correlation to an output device comprises a numerical display.
Clause 9. The method of any of clauses 1-8, wherein providing the joint probability of correlation to an output device comprises: receiving a selection of the CC-ROI; and presenting, in response to receiving the selection of the CC-ROI, the MLO-ROI.
Clause 10. The method of clause 9, further comprising: determining, in response to receiving the selection of the CC-ROI, that the joint probably of correlation exceeds a predetermined threshold; and presenting, in response to determining that the joint probability of correlation exceeds a predetermined threshold, the MLO-ROI.
Clause 11. The method of any of clauses 1-10, wherein the matched pair of ROIs includes a similarity correlation between a CC-ROI in a CC-image and a MLO-ROI in a MLO image, wherein the first confidence level indicator is a probability associated with the correlation between the CC-ROI and the MLO-ROI.
Clause 12. The method of any of clauses 1-11, wherein the second confidence level indicator is a probability associated with a GM correlation between the CC-ROI and the MLO-ROI.
Clause 13. The method of any of clauses 1-12, further comprising: displaying, on the output display, a pair of symbols, wherein each symbol of the pair of symbols marks a ROI of the matched pair of ROIs.
Clause 14. The method of any of clauses 1-13, wherein the data from the GM model comprises location data for each ROI of the matched pair of ROIs.
Clause 15. The method of clause 14, wherein the second confidence level indicator indicates a probability that a first location of a first ROI of the matched pair of ROIs and a second location of a second ROI of the matched pair of ROIS are a same location.
Clause 16. The method of clause 14 or 15, wherein each of the CC image and the MLO image depicts a breast and the GM model logically divides the breast into quadrants.
Clause 17. The method of any of clauses 1-16, wherein the data from the similarity model comprises characteristics data for each ROI of the matched pair of ROIs.
Clause 18. The method of clause 17, wherein the first confidence level indicator indicates a degree of similarity between a first set of characteristics associated with a first ROI of the matched pair of ROI and a second set of characteristics associated with a second ROI of the matched pair of ROIs.
Clause 19. The method of clause 17 or 18, wherein the characteristics data includes one or more of a size, a shape, one or more margins, a location, a density, one or more colors, an orientation, a texture, a pattern, and a depth.
Clause 20. A system for ensemble matching a cranial-caudal (CC) and a medial-lateral-oblique (MLO) image comprising: at least one processor in communication with at least one memory; an ensemble matching module that executes on the at least one processor and during operation is configured to: receive, from a similarity matching model, a matched CC-MLO image pair and a similarity confidence level indicator associated with the matched CC-MLO image pair; receive, from a geometric matching (GM) model, the matched CC-MLO image pair and a GM confidence level indicator associated with the matched CC-MLO image pair; apply an ensemble matching model to determine an ensemble confidence level based on an ensemble machine learning (ML) algorithm trained on a plurality of matched CC-MLO pairs; associate the ensemble confidence level with the matched CC-MLO image pair; and output the ensemble confidence level with the matched CC-MLO image pair.
Clause 21. The system of clause 20, further comprising an image acquisition module.
Clause 22. The system of clause 20 or 21, wherein the matched CC-MLO image pair comprises a first region of interest (ROI) identified in the CC image and a second ROI identified in the MLO image, wherein either of the similarity ML model or the GM model assigns a correlation to the first ROI and the second ROI.
Clause 23. The system of clause 22, wherein the ensemble matching module further receives, from the GM model, location data associated with the correlation between the first ROI and the second ROI.
Clause 24. The system of clause 22 or 23, wherein the ensemble matching module further receives, from the similarity ML model, shape data associated with the correlation between the first ROI and the second ROI.
Clause 25. The system of any of clause 22-24, wherein the ensemble matching module further receives, from the similarity ML model, margin data associated with the correlation between the first ROI and the second ROI.
Clause 26. The system of any of clause 22-25, wherein the similarity matching model determines the matched CC-MLO image pair by: identifying a CC region of interest (ROI) in a CC-image received from an image acquisition module; searching an MLO image received from the image acquisition module for a MLO-ROI, wherein the MLO image includes plurality of regions and the similarity matching model review each region of the plurality of regions; determining at least one similarity characteristic of each of the CC-ROI and the MLO-ROI; and correlating the CC-ROI and the MLO-ROI based on the at least one similarity characteristic.
Clause 27. A method for ensemble matching a cranial-caudal (CC) image and a medial-lateral-oblique (MLO) image comprising: training an ensemble matching model using training CC-MLO image pairs, wherein the training CC-MLO image pairs include pairs of CC-MLO images with regions of interest (ROIs) correlated with high confidence and pairs of CC-MLO images with falsely correlated ROIs; determining, by the ensemble matching model, an ensemble confidence level for a correlation between ROIs in one or more paired CC-MLO images by: receiving a matched CC-MLO pair from a similarity matching model, the matched CC-MLO pair including a similarity confidence score; receiving the matched CC-MLO pair from a geo-matching model, the matched CC-MLO pair including a location confidence score; analyzing the matched CC-MLO pair along with the similarity confidence score and the location confidence score based on the training CC-MLO image pairs; calculating the ensemble confidence level; and generating an output presentation of the ensemble confidence level.
This disclosure described some examples of the present technology with reference to the accompanying drawings, in which only some of the possible examples were shown. Other aspects can, however, be embodied in many different forms and should not be construed as limited to the examples set forth herein. Rather, these examples were provided so that this disclosure was thorough and complete and fully conveyed the scope of the possible examples to those skilled in the art.
Although various embodiments and examples are described herein, those of ordinary skill in the art will understand that many modifications may be made thereto within the scope of the present disclosure. Therefore, the specific structure, acts, or media are disclosed only as illustrative examples. Examples according to the technology may also combine elements or components of those that are disclosed in general but not expressly exemplified in combination, unless otherwise stated herein. Accordingly, it is not intended that the scope of the disclosure in any way be limited by the examples provided.
This application is a continuation of PCT International Patent Application No. PCT/US2022/080432, filed on Nov. 23, 2022, which claims the benefit of U.S. Provisional Application No. 63/283,866, filed Nov. 29, 2021, the entire disclosures of which are incorporated herein by reference in their entireties. To the extent appropriate, a claim of priority is made to each of the above disclosed applications.
Number | Name | Date | Kind |
---|---|---|---|
3502878 | Stewart | Mar 1970 | A |
3863073 | Wagner | Jan 1975 | A |
3971950 | Evans et al. | Jul 1976 | A |
4160906 | Daniels | Jul 1979 | A |
4310766 | Finkenzeller et al. | Jan 1982 | A |
4496557 | Malen et al. | Jan 1985 | A |
4559557 | Keyes | Dec 1985 | A |
4559641 | Caugant et al. | Dec 1985 | A |
4706269 | Reina et al. | Nov 1987 | A |
4727565 | Ericson | Feb 1988 | A |
4744099 | Huettenrauch | May 1988 | A |
4773086 | Fujita | Sep 1988 | A |
4773087 | Plewes | Sep 1988 | A |
4819258 | Kleinman et al. | Apr 1989 | A |
4821727 | Levene et al. | Apr 1989 | A |
4907156 | Doi et al. | Jun 1990 | A |
4969174 | Schied | Nov 1990 | A |
4989227 | Tirelli et al. | Jan 1991 | A |
5018176 | Romeas et al. | May 1991 | A |
RE33634 | Yanaki | Jul 1991 | E |
5029193 | Saffer | Jul 1991 | A |
5051904 | Griffith | Sep 1991 | A |
5078142 | Siczek et al. | Jan 1992 | A |
5099846 | Hardy | Mar 1992 | A |
5129911 | Siczek et al. | Jul 1992 | A |
5133020 | Giger et al. | Jul 1992 | A |
5163075 | Lubinsky | Nov 1992 | A |
5164976 | Scheid et al. | Nov 1992 | A |
5199056 | Darrah | Mar 1993 | A |
5219351 | Teubner | Jun 1993 | A |
5240011 | Assa | Aug 1993 | A |
5279309 | Taylor et al. | Jan 1994 | A |
5280427 | Magnusson | Jan 1994 | A |
5289520 | Pellegrino et al. | Feb 1994 | A |
5343390 | Doi et al. | Aug 1994 | A |
5359637 | Webbe | Oct 1994 | A |
5365562 | Toker | Nov 1994 | A |
5386447 | Siczek | Jan 1995 | A |
5415169 | Siczek et al. | May 1995 | A |
5426685 | Pellegrino et al. | Jun 1995 | A |
5452367 | Bick | Sep 1995 | A |
5491627 | Zhang et al. | Feb 1996 | A |
5499097 | Ortyn et al. | Mar 1996 | A |
5506877 | Niklason et al. | Apr 1996 | A |
5526394 | Siczek | Jun 1996 | A |
5539797 | Heidsieck et al. | Jul 1996 | A |
5553111 | Moore | Sep 1996 | A |
5592562 | Rooks | Jan 1997 | A |
5594769 | Pellegrino et al. | Jan 1997 | A |
5596200 | Sharma | Jan 1997 | A |
5598454 | Franetzki | Jan 1997 | A |
5609152 | Pellegrino et al. | Mar 1997 | A |
5627869 | Andrew et al. | May 1997 | A |
5642433 | Lee et al. | Jun 1997 | A |
5642441 | Riley et al. | Jun 1997 | A |
5647025 | Frost et al. | Jul 1997 | A |
5657362 | Giger et al. | Aug 1997 | A |
5660185 | Shmulewitz et al. | Aug 1997 | A |
5668889 | Hara | Sep 1997 | A |
5671288 | Wilhelm et al. | Sep 1997 | A |
5709206 | Teboul | Jan 1998 | A |
5712890 | Spivey | Jan 1998 | A |
5719952 | Rooks | Feb 1998 | A |
5735264 | Siczek et al. | Apr 1998 | A |
5757880 | Colomb | May 1998 | A |
5763871 | Ortyn et al. | Jun 1998 | A |
5769086 | Ritchart et al. | Jun 1998 | A |
5773832 | Sayed et al. | Jun 1998 | A |
5803912 | Siczek et al. | Sep 1998 | A |
5818898 | Tsukamoto et al. | Oct 1998 | A |
5828722 | Ploetz | Oct 1998 | A |
5835079 | Shieh | Nov 1998 | A |
5841124 | Ortyn et al. | Nov 1998 | A |
5872828 | Niklason et al. | Feb 1999 | A |
5875258 | Ortyn et al. | Feb 1999 | A |
5878104 | Ploetz | Mar 1999 | A |
5878746 | Lemelson et al. | Mar 1999 | A |
5896437 | Ploetz | Apr 1999 | A |
5941832 | Tumey | Aug 1999 | A |
5954650 | Saito | Sep 1999 | A |
5986662 | Argiro | Nov 1999 | A |
6005907 | Ploetz | Dec 1999 | A |
6022325 | Siczek et al. | Feb 2000 | A |
6067079 | Shieh | May 2000 | A |
6075879 | Roehrig et al. | Jun 2000 | A |
6091841 | Rogers | Jul 2000 | A |
6091981 | Cundari et al. | Jul 2000 | A |
6101236 | Wang et al. | Aug 2000 | A |
6102866 | Nields et al. | Aug 2000 | A |
6137527 | Abdel-Malek | Oct 2000 | A |
6141398 | He | Oct 2000 | A |
6149301 | Kautzer et al. | Nov 2000 | A |
6175117 | Komardin | Jan 2001 | B1 |
6196715 | Nambu | Mar 2001 | B1 |
6215892 | Douglass et al. | Apr 2001 | B1 |
6216540 | Nelson | Apr 2001 | B1 |
6219059 | Argiro | Apr 2001 | B1 |
6256370 | Yavus | Apr 2001 | B1 |
6233473 | Sheperd | May 2001 | B1 |
6243441 | Zur | Jun 2001 | B1 |
6245028 | Furst et al. | Jun 2001 | B1 |
6272207 | Tang | Aug 2001 | B1 |
6289235 | Webber et al. | Sep 2001 | B1 |
6292530 | Yavus | Sep 2001 | B1 |
6293282 | Lemelson | Sep 2001 | B1 |
6327336 | Gingold et al. | Dec 2001 | B1 |
6327377 | Rutenberg et al. | Dec 2001 | B1 |
6341156 | Baetz | Jan 2002 | B1 |
6375352 | Hewes | Apr 2002 | B1 |
6389104 | Bani-Hashemi et al. | May 2002 | B1 |
6411836 | Patel | Jun 2002 | B1 |
6415015 | Nicolas | Jul 2002 | B2 |
6424332 | Powell | Jul 2002 | B1 |
6442288 | Haerer | Aug 2002 | B1 |
6459925 | Nields et al. | Oct 2002 | B1 |
6463181 | Duarte | Oct 2002 | B2 |
6468226 | McIntyre, IV | Oct 2002 | B1 |
6480565 | Ning | Nov 2002 | B1 |
6501819 | Unger et al. | Dec 2002 | B2 |
6556655 | Chichereau | Apr 2003 | B1 |
6574304 | Hsieh | Jun 2003 | B1 |
6597762 | Ferrant | Jul 2003 | B1 |
6611575 | Alyassin et al. | Aug 2003 | B1 |
6620111 | Stephens et al. | Sep 2003 | B2 |
6626849 | Huitema et al. | Sep 2003 | B2 |
6633674 | Barnes | Oct 2003 | B1 |
6638235 | Miller et al. | Oct 2003 | B2 |
6647092 | Eberhard | Nov 2003 | B2 |
6650928 | Gailly | Nov 2003 | B1 |
6683934 | Zhao | Jan 2004 | B1 |
6744848 | Stanton | Jun 2004 | B2 |
6748044 | Sabol et al. | Jun 2004 | B2 |
6751285 | Eberhard | Jun 2004 | B2 |
6758824 | Miller et al. | Jul 2004 | B1 |
6813334 | Koppe | Nov 2004 | B2 |
6882700 | Wang | Apr 2005 | B2 |
6885724 | Li | Apr 2005 | B2 |
6901156 | Giger et al. | May 2005 | B2 |
6912319 | Barnes | May 2005 | B1 |
6940943 | Claus | Sep 2005 | B2 |
6978040 | Berestov | Dec 2005 | B2 |
6987331 | Koeppe | Jan 2006 | B2 |
6999553 | Livingston | Feb 2006 | B2 |
6999554 | Mertelmeier | Feb 2006 | B2 |
7022075 | Grunwald et al. | Apr 2006 | B2 |
7025725 | Dione et al. | Apr 2006 | B2 |
7030861 | Westerman | Apr 2006 | B1 |
7110490 | Eberhard | Sep 2006 | B2 |
7110502 | Tsuji | Sep 2006 | B2 |
7117098 | Dunlay et al. | Oct 2006 | B1 |
7123684 | Jing et al. | Oct 2006 | B2 |
7127091 | OpDeBeek | Oct 2006 | B2 |
7142633 | Eberhard | Nov 2006 | B2 |
7218766 | Eberhard | May 2007 | B2 |
7245694 | Jing et al. | Jul 2007 | B2 |
7286634 | Sommer, Jr. et al. | Oct 2007 | B2 |
7289825 | Fors et al. | Oct 2007 | B2 |
7298881 | Giger et al. | Nov 2007 | B2 |
7315607 | Ramsauer | Jan 2008 | B2 |
7319735 | Defreitas et al. | Jan 2008 | B2 |
7323692 | Rowlands | Jan 2008 | B2 |
7346381 | Okerlund et al. | Mar 2008 | B2 |
7406150 | Minyard et al. | Jul 2008 | B2 |
7430272 | Jing et al. | Sep 2008 | B2 |
7443949 | Defreitas et al. | Oct 2008 | B2 |
7466795 | Eberhard et al. | Dec 2008 | B2 |
7556602 | Wang et al. | Jul 2009 | B2 |
7577282 | Gkanatsios et al. | Aug 2009 | B2 |
7606801 | Faitelson et al. | Oct 2009 | B2 |
7616801 | Gkanatsios et al. | Nov 2009 | B2 |
7630533 | Ruth et al. | Dec 2009 | B2 |
7634050 | Muller et al. | Dec 2009 | B2 |
7640051 | Krishnan | Dec 2009 | B2 |
7697660 | Ning | Apr 2010 | B2 |
7702142 | Ren et al. | Apr 2010 | B2 |
7705830 | Westerman et al. | Apr 2010 | B2 |
7760924 | Ruth et al. | Jul 2010 | B2 |
7769219 | Zahniser | Aug 2010 | B2 |
7787936 | Kressy | Aug 2010 | B2 |
7809175 | Roehrig et al. | Oct 2010 | B2 |
7828733 | Zhang et al. | Nov 2010 | B2 |
7831296 | DeFreitas et al. | Nov 2010 | B2 |
7869563 | DeFreitas | Jan 2011 | B2 |
7974924 | Holla et al. | Jul 2011 | B2 |
7991106 | Ren et al. | Aug 2011 | B2 |
8044972 | Hall et al. | Oct 2011 | B2 |
8051386 | Rosander et al. | Nov 2011 | B2 |
8126226 | Bernard et al. | Feb 2012 | B2 |
8155421 | Ren et al. | Apr 2012 | B2 |
8165365 | Bernard et al. | Apr 2012 | B2 |
8532745 | DeFreitas et al. | Sep 2013 | B2 |
8571289 | Ruth | Oct 2013 | B2 |
8594274 | Hoernig et al. | Nov 2013 | B2 |
8677282 | Cragun et al. | Mar 2014 | B2 |
8712127 | Ren et al. | Apr 2014 | B2 |
8787522 | Smith et al. | Jul 2014 | B2 |
8897535 | Ruth et al. | Nov 2014 | B2 |
8983156 | Periaswamy et al. | Mar 2015 | B2 |
9020579 | Smith | Apr 2015 | B2 |
9075903 | Marshall | Jul 2015 | B2 |
9084579 | Ren et al. | Jul 2015 | B2 |
9119599 | Itai | Sep 2015 | B2 |
9129362 | Jerebko | Sep 2015 | B2 |
9289183 | Karssemeijer | Mar 2016 | B2 |
9451924 | Bernard | Sep 2016 | B2 |
9456797 | Ruth et al. | Oct 2016 | B2 |
9478028 | Parthasarathy | Oct 2016 | B2 |
9589374 | Gao | Mar 2017 | B1 |
9592019 | Sugiyama | Mar 2017 | B2 |
9805507 | Chen | Oct 2017 | B2 |
9808215 | Ruth et al. | Nov 2017 | B2 |
9811758 | Ren et al. | Nov 2017 | B2 |
9901309 | DeFreitas et al. | Feb 2018 | B2 |
10008184 | Kreeger et al. | Jun 2018 | B2 |
10010302 | Ruth et al. | Jul 2018 | B2 |
10074199 | Robinson et al. | Sep 2018 | B2 |
10092358 | DeFreitas | Oct 2018 | B2 |
10111631 | Gkanatsios | Oct 2018 | B2 |
10242490 | Karssemeijer | Mar 2019 | B2 |
10276265 | Reicher et al. | Apr 2019 | B2 |
10282840 | Moehrle et al. | May 2019 | B2 |
10335094 | DeFreitas | Jul 2019 | B2 |
10357211 | Smith | Jul 2019 | B2 |
10410417 | Chen et al. | Sep 2019 | B2 |
10413263 | Ruth et al. | Sep 2019 | B2 |
10444960 | Marshall | Oct 2019 | B2 |
10456213 | DeFreitas | Oct 2019 | B2 |
10573276 | Kreeger et al. | Feb 2020 | B2 |
10575807 | Gkanatsios | Mar 2020 | B2 |
10595954 | DeFreitas | Mar 2020 | B2 |
10624598 | Chen | Apr 2020 | B2 |
10977863 | Chen | Apr 2021 | B2 |
10978026 | Kreeger | Apr 2021 | B2 |
11419565 | Gkanatsios | Aug 2022 | B2 |
11508340 | Kreeger | Nov 2022 | B2 |
11589944 | DeFreitas | Feb 2023 | B2 |
11663780 | Chen | May 2023 | B2 |
11701199 | DeFreitas | Jul 2023 | B2 |
20010038681 | Stanton et al. | Nov 2001 | A1 |
20010038861 | Hsu et al. | Nov 2001 | A1 |
20020012450 | Tsuji | Jan 2002 | A1 |
20020050986 | Inoue | May 2002 | A1 |
20020075997 | Unger et al. | Jun 2002 | A1 |
20020113681 | Byram | Aug 2002 | A1 |
20020122533 | Marie et al. | Sep 2002 | A1 |
20020188466 | Barrette et al. | Dec 2002 | A1 |
20020193676 | Bodicker | Dec 2002 | A1 |
20030007598 | Wang | Jan 2003 | A1 |
20030018272 | Treado et al. | Jan 2003 | A1 |
20030026386 | Tang | Feb 2003 | A1 |
20030048260 | Matusis | Mar 2003 | A1 |
20030073895 | Nields et al. | Apr 2003 | A1 |
20030095624 | Eberhard et al. | May 2003 | A1 |
20030097055 | Yanof | May 2003 | A1 |
20030128893 | Castorina | Jul 2003 | A1 |
20030135115 | Burdette et al. | Jul 2003 | A1 |
20030169847 | Karellas | Sep 2003 | A1 |
20030194050 | Eberhard | Oct 2003 | A1 |
20030194121 | Eberhard et al. | Oct 2003 | A1 |
20030194124 | Suzuki et al. | Oct 2003 | A1 |
20030195433 | Turovskiy | Oct 2003 | A1 |
20030210254 | Doan | Nov 2003 | A1 |
20030212327 | Wang | Nov 2003 | A1 |
20030215120 | Uppaluri | Nov 2003 | A1 |
20040008809 | Webber | Jan 2004 | A1 |
20040008900 | Jabri et al. | Jan 2004 | A1 |
20040008901 | Avinash | Jan 2004 | A1 |
20040036680 | Davis | Feb 2004 | A1 |
20040047518 | Tiana | Mar 2004 | A1 |
20040052328 | Saboi | Mar 2004 | A1 |
20040064037 | Smith | Apr 2004 | A1 |
20040066884 | Claus | Apr 2004 | A1 |
20040066904 | Eberhard et al. | Apr 2004 | A1 |
20040070582 | Smith et al. | Apr 2004 | A1 |
20040077938 | Mark et al. | Apr 2004 | A1 |
20040081273 | Ning | Apr 2004 | A1 |
20040094167 | Brady | May 2004 | A1 |
20040101095 | Jing et al. | May 2004 | A1 |
20040109028 | Stern et al. | Jun 2004 | A1 |
20040109529 | Eberhard et al. | Jun 2004 | A1 |
20040127789 | Ogawa | Jul 2004 | A1 |
20040138569 | Grunwald | Jul 2004 | A1 |
20040171933 | Stoller et al. | Sep 2004 | A1 |
20040171986 | Tremaglio, Jr. et al. | Sep 2004 | A1 |
20040267157 | Miller et al. | Dec 2004 | A1 |
20050047636 | Gines et al. | Mar 2005 | A1 |
20050049521 | Miller et al. | Mar 2005 | A1 |
20050063509 | Defreitas et al. | Mar 2005 | A1 |
20050078797 | Danielsson et al. | Apr 2005 | A1 |
20050084060 | Seppi et al. | Apr 2005 | A1 |
20050089205 | Kapur | Apr 2005 | A1 |
20050105679 | Wu et al. | May 2005 | A1 |
20050107689 | Sasano | May 2005 | A1 |
20050111718 | MacMahon | May 2005 | A1 |
20050113680 | Ikeda et al. | May 2005 | A1 |
20050113681 | DeFreitas et al. | May 2005 | A1 |
20050113715 | Schwindt et al. | May 2005 | A1 |
20050124845 | Thomadsen et al. | Jun 2005 | A1 |
20050135555 | Claus | Jun 2005 | A1 |
20050135664 | Kaufhold | Jun 2005 | A1 |
20050226375 | Eberhard | Oct 2005 | A1 |
20060004278 | Giger et al. | Jan 2006 | A1 |
20060009693 | Hanover et al. | Jan 2006 | A1 |
20060018526 | Avinash | Jan 2006 | A1 |
20060025680 | Jeune-Iomme | Feb 2006 | A1 |
20060030784 | Miller et al. | Feb 2006 | A1 |
20060074288 | Kelly et al. | Apr 2006 | A1 |
20060098855 | Gkanatsios et al. | May 2006 | A1 |
20060129062 | Nicoson et al. | Jun 2006 | A1 |
20060132508 | Sadikali | Jun 2006 | A1 |
20060147099 | Marshall et al. | Jul 2006 | A1 |
20060154267 | Ma et al. | Jul 2006 | A1 |
20060155209 | Miller et al. | Jul 2006 | A1 |
20060197753 | Hotelling | Sep 2006 | A1 |
20060210131 | Wheeler | Sep 2006 | A1 |
20060228012 | Masuzawa | Oct 2006 | A1 |
20060238546 | Handley | Oct 2006 | A1 |
20060257009 | Wang | Nov 2006 | A1 |
20060269040 | Mertelmeier | Nov 2006 | A1 |
20060274928 | Collins et al. | Dec 2006 | A1 |
20060291618 | Eberhard et al. | Dec 2006 | A1 |
20070014468 | Gines et al. | Jan 2007 | A1 |
20070019846 | Bullitt et al. | Jan 2007 | A1 |
20070030949 | Jing et al. | Feb 2007 | A1 |
20070036265 | Jing et al. | Feb 2007 | A1 |
20070046649 | Reiner | Mar 2007 | A1 |
20070047793 | Wu et al. | Mar 2007 | A1 |
20070052700 | Wheeler et al. | Mar 2007 | A1 |
20070076844 | Defreitas et al. | Apr 2007 | A1 |
20070114424 | Danielsson et al. | May 2007 | A1 |
20070118400 | Morita et al. | May 2007 | A1 |
20070156451 | Gering | Jul 2007 | A1 |
20070223651 | Wagenaar et al. | Sep 2007 | A1 |
20070225600 | Weibrecht et al. | Sep 2007 | A1 |
20070236490 | Casteele | Oct 2007 | A1 |
20070242800 | Jing et al. | Oct 2007 | A1 |
20070263765 | Wu | Nov 2007 | A1 |
20070274585 | Zhang et al. | Nov 2007 | A1 |
20080019581 | Gkanatsios et al. | Jan 2008 | A1 |
20080043905 | Hassanpourgol | Feb 2008 | A1 |
20080045833 | DeFreitas et al. | Feb 2008 | A1 |
20080101537 | Sendai | May 2008 | A1 |
20080114614 | Mahesh et al. | May 2008 | A1 |
20080125643 | Huisman | May 2008 | A1 |
20080130979 | Ren | Jun 2008 | A1 |
20080139896 | Baumgart | Jun 2008 | A1 |
20080152086 | Hall | Jun 2008 | A1 |
20080165136 | Christie et al. | Jul 2008 | A1 |
20080187095 | Boone et al. | Aug 2008 | A1 |
20080198966 | Hjarn | Aug 2008 | A1 |
20080221479 | Ritchie | Sep 2008 | A1 |
20080229256 | Shibaike | Sep 2008 | A1 |
20080240533 | Piron et al. | Oct 2008 | A1 |
20080297482 | Weiss | Dec 2008 | A1 |
20090003519 | DeFreitas | Jan 2009 | A1 |
20090005668 | West et al. | Jan 2009 | A1 |
20090005693 | Brauner | Jan 2009 | A1 |
20090010384 | Jing et al. | Jan 2009 | A1 |
20090034684 | Bernard | Feb 2009 | A1 |
20090037821 | O'Neal et al. | Feb 2009 | A1 |
20090063118 | Dachille et al. | Mar 2009 | A1 |
20090079705 | Sizelove et al. | Mar 2009 | A1 |
20090080594 | Brooks et al. | Mar 2009 | A1 |
20090080602 | Brooks et al. | Mar 2009 | A1 |
20090080604 | Shores et al. | Mar 2009 | A1 |
20090080752 | Ruth | Mar 2009 | A1 |
20090080765 | Bernard et al. | Mar 2009 | A1 |
20090087067 | Khorasani | Apr 2009 | A1 |
20090123052 | Ruth | May 2009 | A1 |
20090129644 | Daw et al. | May 2009 | A1 |
20090135997 | Defreitas et al. | May 2009 | A1 |
20090138280 | Morita et al. | May 2009 | A1 |
20090143674 | Nields | Jun 2009 | A1 |
20090167702 | Nurmi | Jul 2009 | A1 |
20090171244 | Ning | Jul 2009 | A1 |
20090238424 | Arakita | Sep 2009 | A1 |
20090259958 | Ban | Oct 2009 | A1 |
20090268865 | Ren et al. | Oct 2009 | A1 |
20090278812 | Yasutake | Nov 2009 | A1 |
20090296882 | Gkanatsios et al. | Dec 2009 | A1 |
20090304147 | Jing et al. | Dec 2009 | A1 |
20100034348 | Yu | Feb 2010 | A1 |
20100049046 | Peiffer | Feb 2010 | A1 |
20100054400 | Ren et al. | Mar 2010 | A1 |
20100067648 | Kojima | Mar 2010 | A1 |
20100079405 | Bernstein | Apr 2010 | A1 |
20100086188 | Ruth et al. | Apr 2010 | A1 |
20100088346 | Urness et al. | Apr 2010 | A1 |
20100098214 | Star-Lack et al. | Apr 2010 | A1 |
20100105879 | Katayose et al. | Apr 2010 | A1 |
20100121178 | Krishnan | May 2010 | A1 |
20100131294 | Venon | May 2010 | A1 |
20100131482 | Linthicum et al. | May 2010 | A1 |
20100135558 | Ruth et al. | Jun 2010 | A1 |
20100152570 | Navab | Jun 2010 | A1 |
20100166147 | Abenaim | Jul 2010 | A1 |
20100166267 | Zhang | Jul 2010 | A1 |
20100171764 | Feng et al. | Jul 2010 | A1 |
20100189322 | Sakagawa | Jul 2010 | A1 |
20100195882 | Ren et al. | Aug 2010 | A1 |
20100208037 | Sendai | Aug 2010 | A1 |
20100231522 | Li | Sep 2010 | A1 |
20100246884 | Chen et al. | Sep 2010 | A1 |
20100246909 | Blum | Sep 2010 | A1 |
20100259561 | Forutanpour et al. | Oct 2010 | A1 |
20100259645 | Kaplan | Oct 2010 | A1 |
20100260316 | Stein et al. | Oct 2010 | A1 |
20100280375 | Zhang | Nov 2010 | A1 |
20100293500 | Cragun | Nov 2010 | A1 |
20110018817 | Kryze | Jan 2011 | A1 |
20110019891 | Puong | Jan 2011 | A1 |
20110054944 | Sandberg et al. | Mar 2011 | A1 |
20110069808 | Defreitas et al. | Mar 2011 | A1 |
20110069906 | Park | Mar 2011 | A1 |
20110087132 | DeFreitas et al. | Apr 2011 | A1 |
20110105879 | Masumoto | May 2011 | A1 |
20110109650 | Kreeger | May 2011 | A1 |
20110110570 | Bar-Shalev | May 2011 | A1 |
20110110576 | Kreeger | May 2011 | A1 |
20110123073 | Gustafson | May 2011 | A1 |
20110125526 | Gustafson | May 2011 | A1 |
20110134113 | Ma et al. | Jun 2011 | A1 |
20110150447 | Li | Jun 2011 | A1 |
20110157154 | Bernard et al. | Jun 2011 | A1 |
20110163939 | Tam et al. | Jul 2011 | A1 |
20110178389 | Kumar et al. | Jul 2011 | A1 |
20110182402 | Partain | Jul 2011 | A1 |
20110234630 | Batman et al. | Sep 2011 | A1 |
20110237927 | Brooks et al. | Sep 2011 | A1 |
20110242092 | Kashiwagi | Oct 2011 | A1 |
20110310126 | Georgiev et al. | Dec 2011 | A1 |
20120014501 | Pelc | Jan 2012 | A1 |
20120014504 | Jang | Jan 2012 | A1 |
20120014578 | Karssemeijer | Jan 2012 | A1 |
20120069951 | Toba | Mar 2012 | A1 |
20120106698 | Karim | May 2012 | A1 |
20120127297 | Baxi | May 2012 | A1 |
20120131488 | Karlsson et al. | May 2012 | A1 |
20120133600 | Marshall | May 2012 | A1 |
20120133601 | Marshall | May 2012 | A1 |
20120134464 | Hoernig et al. | May 2012 | A1 |
20120148151 | Hamada | Jun 2012 | A1 |
20120150034 | DeFreitas et al. | Jun 2012 | A1 |
20120189092 | Jerebko | Jul 2012 | A1 |
20120194425 | Buelow | Aug 2012 | A1 |
20120238870 | Smith et al. | Sep 2012 | A1 |
20120277625 | Nakayama | Nov 2012 | A1 |
20120293511 | Mertelmeier | Nov 2012 | A1 |
20130016255 | Bhatt | Jan 2013 | A1 |
20130022165 | Jang | Jan 2013 | A1 |
20130044861 | Muller | Feb 2013 | A1 |
20130059758 | Haick | Mar 2013 | A1 |
20130108138 | Nakayama | May 2013 | A1 |
20130121569 | Yadav | May 2013 | A1 |
20130121618 | Yadav | May 2013 | A1 |
20130202168 | Jerebko | Aug 2013 | A1 |
20130259193 | Packard | Oct 2013 | A1 |
20130272494 | DeFreitas | Oct 2013 | A1 |
20140033126 | Kreeger | Jan 2014 | A1 |
20140035811 | Guehring | Feb 2014 | A1 |
20140064444 | Oh | Mar 2014 | A1 |
20140073913 | DeFreitas et al. | Mar 2014 | A1 |
20140082542 | Zhang et al. | Mar 2014 | A1 |
20140200433 | Choi | Jul 2014 | A1 |
20140219534 | Wiemker et al. | Aug 2014 | A1 |
20140219548 | Wels | Aug 2014 | A1 |
20140276061 | Lee et al. | Sep 2014 | A1 |
20140327702 | Kreeger et al. | Nov 2014 | A1 |
20140328517 | Gluncic | Nov 2014 | A1 |
20150004558 | Inglese | Jan 2015 | A1 |
20150052471 | Chen | Feb 2015 | A1 |
20150061582 | Smith | Apr 2015 | A1 |
20150238148 | Georgescu | Aug 2015 | A1 |
20150258271 | Love | Sep 2015 | A1 |
20150302146 | Marshall | Oct 2015 | A1 |
20150309712 | Marshall | Oct 2015 | A1 |
20150317538 | Ren et al. | Nov 2015 | A1 |
20150331995 | Zhao | Nov 2015 | A1 |
20160000399 | Halmann et al. | Jan 2016 | A1 |
20160022364 | DeFreitas et al. | Jan 2016 | A1 |
20160051215 | Chen | Feb 2016 | A1 |
20160078645 | Abdurahman | Mar 2016 | A1 |
20160140749 | Erhard | May 2016 | A1 |
20160210774 | Wiskin et al. | Jul 2016 | A1 |
20160228034 | Gluncic | Aug 2016 | A1 |
20160235380 | Smith | Aug 2016 | A1 |
20160350933 | Schieke | Dec 2016 | A1 |
20160364526 | Reicher et al. | Dec 2016 | A1 |
20160367210 | Gkanatsios | Dec 2016 | A1 |
20170071562 | Suzuki | Mar 2017 | A1 |
20170132792 | Jerebko et al. | May 2017 | A1 |
20170202453 | Sekiguchi | Jul 2017 | A1 |
20170262737 | Rabinovich | Sep 2017 | A1 |
20180008220 | Boone et al. | Jan 2018 | A1 |
20180008236 | Venkataraman et al. | Jan 2018 | A1 |
20180047211 | Chen et al. | Feb 2018 | A1 |
20180109698 | Ramsay et al. | Apr 2018 | A1 |
20180132722 | Eggers et al. | May 2018 | A1 |
20180137385 | Ren | May 2018 | A1 |
20180144244 | Masoud | May 2018 | A1 |
20180256118 | DeFreitas | Sep 2018 | A1 |
20190000318 | Caluser | Jan 2019 | A1 |
20190015173 | DeFreitas | Jan 2019 | A1 |
20190037173 | Lee et al. | Jan 2019 | A1 |
20190043456 | Kreeger | Feb 2019 | A1 |
20190057778 | Porter et al. | Feb 2019 | A1 |
20190287241 | Hill et al. | Sep 2019 | A1 |
20190290221 | Smith | Sep 2019 | A1 |
20190325573 | Bernard et al. | Oct 2019 | A1 |
20200046303 | DeFreitas | Feb 2020 | A1 |
20200054300 | Kreeger et al. | Feb 2020 | A1 |
20200093562 | DeFreitas | Mar 2020 | A1 |
20200184262 | Chui | Jun 2020 | A1 |
20200205928 | DeFreitas | Jul 2020 | A1 |
20200253573 | Gkanatsios | Aug 2020 | A1 |
20200345320 | Chen | Nov 2020 | A1 |
20200390404 | DeFreitas | Dec 2020 | A1 |
20210000553 | St. Pierre | Jan 2021 | A1 |
20210100518 | Chui | Apr 2021 | A1 |
20210100626 | St. Pierre | Apr 2021 | A1 |
20210113167 | Chui | Apr 2021 | A1 |
20210118199 | Chui | Apr 2021 | A1 |
20210174504 | Madabhushi | Jun 2021 | A1 |
20210212665 | Tsymbalenko | Jul 2021 | A1 |
20220005277 | Chen | Jan 2022 | A1 |
20220013089 | Kreeger | Jan 2022 | A1 |
20220036545 | St. Pierre | Feb 2022 | A1 |
20220192615 | Chui | Jun 2022 | A1 |
20220254023 | McKinney et al. | Aug 2022 | A1 |
20220386969 | Smith | Dec 2022 | A1 |
20230000467 | Shi | Jan 2023 | A1 |
20230008465 | Smith | Jan 2023 | A1 |
20230033601 | Chui | Feb 2023 | A1 |
20230038498 | Xu | Feb 2023 | A1 |
20230053489 | Kreeger | Feb 2023 | A1 |
20230054121 | Chui | Feb 2023 | A1 |
20230056692 | Gkanatsios | Feb 2023 | A1 |
20230082494 | Chui | Mar 2023 | A1 |
20230098305 | St. Pierre | Mar 2023 | A1 |
20230103969 | St. Pierre | Apr 2023 | A1 |
20230124481 | St. Pierre | Apr 2023 | A1 |
20230125385 | Solis | Apr 2023 | A1 |
20230225821 | DeFreitas | Jul 2023 | A1 |
20230230679 | Chen | Jul 2023 | A1 |
20230240785 | DeFreitas | Aug 2023 | A1 |
20230344453 | Yang | Oct 2023 | A1 |
20230394769 | Chen | Dec 2023 | A1 |
20240169958 | Kreeger | May 2024 | A1 |
20240315654 | Chui | Sep 2024 | A1 |
20240338864 | Chui | Oct 2024 | A1 |
20240341698 | DeFreitas | Oct 2024 | A1 |
Number | Date | Country |
---|---|---|
2014339982 | Apr 2015 | AU |
1802121 | Jul 2006 | CN |
1846622 | Oct 2006 | CN |
101066212 | Nov 2007 | CN |
102169530 | Aug 2011 | CN |
202161328 | Mar 2012 | CN |
102429678 | May 2012 | CN |
102473300 | May 2012 | CN |
105193447 | Dec 2015 | CN |
106659468 | May 2017 | CN |
107440730 | Dec 2017 | CN |
112561908 | Mar 2021 | CN |
102010009295 | Aug 2011 | DE |
102011087127 | May 2013 | DE |
775467 | May 1997 | EP |
982001 | Mar 2000 | EP |
1428473 | Jun 2004 | EP |
2236085 | Jun 2010 | EP |
2215600 | Aug 2010 | EP |
2301432 | Mar 2011 | EP |
2491863 | Aug 2012 | EP |
1986548 | Jan 2013 | EP |
2656789 | Oct 2013 | EP |
2823464 | Jan 2015 | EP |
2823765 | Jan 2015 | EP |
2889743 | Jul 2015 | EP |
3060132 | Apr 2019 | EP |
H09-35043 | Feb 1997 | JP |
H09-198490 | Jul 1997 | JP |
H09-238934 | Sep 1997 | JP |
H10-33523 | Feb 1998 | JP |
2000-200340 | Jul 2000 | JP |
2002-109510 | Apr 2002 | JP |
2002-282248 | Oct 2002 | JP |
2003-126073 | May 2003 | JP |
2003-189179 | Jul 2003 | JP |
2003-199737 | Jul 2003 | JP |
2003-531516 | Oct 2003 | JP |
2004254742 | Sep 2004 | JP |
2005-110843 | Apr 2005 | JP |
2005-522305 | Jul 2005 | JP |
2005-227350 | Aug 2005 | JP |
2005-322257 | Nov 2005 | JP |
2006-519634 | Aug 2006 | JP |
2006-312026 | Nov 2006 | JP |
2007-130487 | May 2007 | JP |
2007-216022 | Aug 2007 | JP |
2007-325928 | Dec 2007 | JP |
2007-330334 | Dec 2007 | JP |
2007-536968 | Dec 2007 | JP |
2008-068032 | Mar 2008 | JP |
2008518684 | Jun 2008 | JP |
2008-253401 | Oct 2008 | JP |
2009-034503 | Feb 2009 | JP |
2009-522005 | Jun 2009 | JP |
2009-526618 | Jul 2009 | JP |
2009-207545 | Sep 2009 | JP |
2010-137004 | Jun 2010 | JP |
2011-110175 | Jun 2011 | JP |
2012-011255 | Jan 2012 | JP |
2012-501750 | Jan 2012 | JP |
2012-061196 | Mar 2012 | JP |
2013-530768 | Aug 2013 | JP |
2013-244211 | Dec 2013 | JP |
2014-507250 | Mar 2014 | JP |
2014-534042 | Dec 2014 | JP |
2015-506794 | Mar 2015 | JP |
2015-144632 | Aug 2015 | JP |
2016-198197 | Dec 2015 | JP |
2016059743 | Apr 2016 | JP |
2017-000364 | Jan 2017 | JP |
2017-056358 | Mar 2017 | JP |
10-2015-0010515 | Jan 2015 | KR |
10-2017-0062839 | Jun 2017 | KR |
9005485 | May 1990 | WO |
9317620 | Sep 1993 | WO |
9406352 | Mar 1994 | WO |
199700649 | Jan 1997 | WO |
199816903 | Apr 1998 | WO |
0051484 | Sep 2000 | WO |
2003020114 | Mar 2003 | WO |
03077202 | Sep 2003 | WO |
2005051197 | Jun 2005 | WO |
2005110230 | Nov 2005 | WO |
2005112767 | Dec 2005 | WO |
2006055830 | May 2006 | WO |
2006058160 | Jun 2006 | WO |
2007095330 | Aug 2007 | WO |
08014670 | Feb 2008 | WO |
2008047270 | Apr 2008 | WO |
2008050823 | May 2008 | WO |
2008054436 | May 2008 | WO |
2009026587 | Feb 2009 | WO |
2010028208 | Mar 2010 | WO |
2010059920 | May 2010 | WO |
2011008239 | Jan 2011 | WO |
2011043838 | Apr 2011 | WO |
2011065950 | Jun 2011 | WO |
2011073864 | Jun 2011 | WO |
2011091300 | Jul 2011 | WO |
2012001572 | Jan 2012 | WO |
2012068373 | May 2012 | WO |
2012063653 | May 2012 | WO |
2012112627 | Aug 2012 | WO |
2012122399 | Sep 2012 | WO |
2013001439 | Jan 2013 | WO |
2013035026 | Mar 2013 | WO |
2013087476 | May 2013 | WO |
2013123091 | Aug 2013 | WO |
2013136222 | Sep 2013 | WO |
2014080215 | May 2014 | WO |
2014149554 | Sep 2014 | WO |
2014207080 | Dec 2014 | WO |
2015061582 | Apr 2015 | WO |
2015066650 | May 2015 | WO |
2015130916 | Sep 2015 | WO |
2016103094 | Jun 2016 | WO |
2016184746 | Nov 2016 | WO |
2016206942 | Dec 2016 | WO |
2018183548 | Oct 2018 | WO |
2018183549 | Oct 2018 | WO |
2018183550 | Oct 2018 | WO |
2018236565 | Dec 2018 | WO |
2019032558 | Feb 2019 | WO |
2019091807 | May 2019 | WO |
2021021329 | Feb 2021 | WO |
2021168281 | Aug 2021 | WO |
2021195084 | Sep 2021 | WO |
Entry |
---|
Perek, S. et al. “Siamese network for dual-view mammography mass matching.” Image Analysis for Moving Organ, Breast&Thoracic Images: 3rd Int'l Workshop, Rambo 2018, 4th Int'l Workshop, BIA 2018, and 1st Int'l Workshop, TIA 2018, Proceedings 3. Springer International Publishing, 2018. (Year: 2018). |
PCT International Search Report and Written Opinion in International Application PCT/US2022/080432, mailed Mar. 22, 2023, 17 pages. |
“Filtered Back Projection”, (Nygren), published May 8, 2007, URL: http://web.archive.org/web/19991010131715/http://www.owlnet.rice.edu/˜elec539/Projects97/cult/node2.html, 2 pgs. |
“Supersonic to feature Aixplorer Ultimate at ECR”, AuntiMinnie.com, 3 pages (Feb. 2018). |
Al Sallab et al., “Self Learning Machines Using Deep Networks”, Soft Computing and Pattern Recognition (SoCPaR), 2011 Int'l. Conference of IEEE, Oct. 14, 2011, pp. 21-26. |
Berg, WA et al., “Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer”, JAMA 299:2151-2163, 2008. |
Burbank, Fred, “Stereotactic Breast Biopsy: Its History, Its Present, and Its Future”, published in 1996 at the Southeastern Surgical Congress, 24 pages. |
Bushberg, Jerrold et al., “The Essential Physics of Medical Imaging”, 3rd ed., In: “The Essential Physics of Medical Imaging, Third Edition”, Dec. 28, 2011, Lippincott & Wilkins, Philadelphia, PA, USA, XP05579051, pp. 270-272. |
Caroline, B.E. et al., “Computer aided detection of masses in digital breast tomosynthesis: A review”, 2012 International Conference on Emerging Trends in Science, Engineering and Technology (INCOSET), Tiruchirappalli, 2012, pp. 186-191. |
Carton, AK, et al., “Dual-energy contrast-enhanced digital breast tomosynthesis—a feasibility study”, BR J Radiol. Apr. 2010;83 (988):344-50. |
Chan, Heang-Ping et al., “Computer-aided detection system for breast masses on digital tomosynthesis mammograms: Preliminary Experience”, Radiology, Dec. 2005, 1075-1080. |
Chan, Heang-Ping et al., “ROC Study of the effect of stereoscopic imaging on assessment of breast lesions,” Medical Physics, vol. 32, No. 4, Apr. 2005, 1001-1009. |
Chen, SC, et al., “Initial clinical experience with contrast-enhanced digital breast tomosynthesis”, Acad Radio. Feb. 2007 14(2):229-38. |
Cho, N. et al., “Distinguishing Benign from Malignant Masses at Breast US: Combined US Elastography and Color Doppler US-Influence on Radiologist Accuracy”, Radiology, 262(1): 80-90 (Jan. 2012). |
Conner, Peter, “Breast Response to Menopausal Hormone Therapy—Aspects on Proliferation, apoptosis and Mammographic Density”, 2007 Annals of Medicine, 39;1, 28-41. |
Diekmann, Felix et al., “Thick Slices from Tomosynthesis Data Sets: Phantom Study for the Evaluation of Different Algorithms”, Journal of Digital Imaging, Springer, vol. 22, No. 5, Oct. 23, 2007, pp. 519-526. |
Diekmann, Felix., et al., “Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement”, Invest Radiol 2005; 40:397-404. |
Dromain C., et al., “Contrast enhanced spectral mammography: a multi-reader study”, RSNA 2010, 96th Scientific Assembly and Scientific Meeting. |
Dromain, C., et al., “Contrast-enhanced digital mammography”, Eur J Radiol. 2009; 69:34-42. |
Dromain, Clarisse et al., “Dual-energy contrast-enhanced digital mammography: initial clinical results”, European Radiology, Sep. 14, 2010, vol. 21, pp. 565-574. |
Dromain, Clarisse, et al., “Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography”, AJR: 187, Nov. 2006, 16 pages. |
Duan, Xiaoman et al., “Matching corresponding regions of interest on cranio-caudal and medio-lateral oblique view mammograms”, IEEE Access, vol. 7, Mar. 25, 2019, pp. 31586-31597, XP011715754, DOI: 10.1109/Access.2019.2902854, retrieved on Mar. 20, 2019, abstract. |
E. Shaw de Paredes et al., “Interventional Breast Procedure”, published Sep./Oct. 1998 in Curr Probl Diagn Radiol, pp. 138-184. |
EFilm Mobile HD by Merge Healthcare, web site: http://itunes.apple.com/bw/app/efilm-mobile-hd/id405261243?mt=8, accessed on Nov. 3, 2011 (2 pages). |
EFilm Solutions, eFilm Workstation (tm) 3.4, website: http://estore.merge.com/na/estore/content.aspx?productID=405, accessed on Nov. 3, 2011 (2 pages). |
Elbakri, Idris A. et al., “Automatic exposure control for a slot scanning full field digital mammography system”, Med. Phys. 2005; Sep. 32(9):2763-2770, Abstract only. |
Ertas, M. et al., “2D versus 3D total variation minimization in digital breast tomosynthesis”, 2015 IEEE International Conference on Imaging Systems and Techniques (IST), Macau, 2015, pp. 1-4. |
Feng, Steve Si Jia, et al., “Clinical digital breast tomosynthesis system: Dosimetric Characterization”, Radiology, Apr. 2012, 263(1); pp. 35-42. |
Fischer Imaging Corp, Mammotest Plus manual on minimally invasive breast biopsy system, 2002, 8 pages. |
Fischer Imaging Corporation, Installation Manual, MammoTest Family of Breast Biopsy Systems, 86683G, 86684G, P-55957-IM, Issue 1, Revision 3, Jul. 2005, 98 pages. |
Fischer Imaging Corporation, Operator Manual, MammoTest Family of Breast Biopsy Systems, 86683G, 86684G, P-55956-OM, Issue 1, Revision 6, Sep. 2005, 258 pages. |
Freiherr, G., “Breast tomosynthesis trials show promise”, Diagnostic Imaging—San Francisco 2005, V27; N4:42-48. |
Georgian-Smith, Dianne, et al., “Stereotactic Biopsy of the Breast Using an Upright Unit, a Vacuum-Suction Needle, and a Lateral Arm-Support System”, 2001, at the American Roentgen Ray Society meeting, 8 pages. |
Ghiassi, M. et al., “A Dynamic Architecture for Artificial Networks”, Neurocomputing, vol. 63, Aug. 20, 2004, pp. 397-413. |
Giger et al. “Development of a smart workstation for use in mammography”, in Proceedings of SPIE, vol. 1445 (1991), pp. 101103; 4 pages. |
Giger et al., “An Intelligent Workstation for Computer-aided Diagnosis”, in RadioGraphics, May 1993, 13:3 pp. 647-656; 10 pages. |
Glick, Stephen J., “Breast CT”, Annual Rev. Biomed. Eng., 2007, 9;501-26. |
Green, C. et al., “Deformable mapping using biochemical models to relate corresponding lesions in digital breast tomosynthesis and automated breast ultrasound images”, Medical Image Analysis, 60: 1-18 (Nov. 2019). |
Hologic, “Lorad StereoLoc II” Operator's Manual 9-500-0261, Rev. 005, 2004, 78 pgs. |
Hologic, Inc., 510(k) Summary, prepared Nov. 28, 2010, for Affirm Breast Biopsy Guidance System Special 510(k) Premarket Notification, 5 pages. |
Hologic, Inc., 510(k) Summary, prepared Aug. 14, 2012, for Affirm Breast Biopsy Guidance System Special 510(k) Premarket Notification, 5 pages. |
ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection, 12 pages. |
Ijaz, Umer Zeeshan, et al., “Mammography phantom studies using 3D electrical impedance tomography with numerical forward solver”, Frontiers in the Convergence of Bioscience and Information Technologies 2007, 379-383. |
Jochelson, M., et al., “Bilateral Dual Energy contrast-enhanced digital mammography: Initial Experience”, RSNA 2010, 96th Scientific Assembly and Scientific Meeting, 1 page. |
Jong, RA, et al., Contrast-enhanced digital mammography: initial clinical experience. Radiology 2003; 228:842-850. |
Kao, Tzu-Jen et al., “Regional admittivity spectra with tomosynthesis images for breast cancer detection”, Proc. of the 29th Annual Int'l. Conf. of the IEEE EMBS, Aug. 23-26, 2007, 4142-4145. |
Kim, Eun Sil, et al., “Significance of microvascular evaluation of ductal lesions on breast ultrasonography: Influence on diagnostic performance”, Clinical Imaging, Elsevier, NY, vol. 51, Jun. 6, 2018, pp. 252-259. |
Koechli, Ossi R., “Available Sterotactic Systems for Breast Biopsy”, Renzo Brun del Re (Ed.), Minimally Invasive Breast Biopsies, Recent Results in Cancer Research 173:105-113; Springer-Verlag, 2009. |
Kopans, Daniel B., “Breast Imaging”, 3rd Edition, Lippincott Williams and Wilkins, published Nov. 2, 2006, pp. 960-967. |
Kopans, et al. Will tomosynthesis replace conventional mammography? Plenary Session SFN08: RSNA 2005. |
Lee, E. et al., “Combination of Quantitative Parameters of Shear Wave Elastography and Superb Microvascular Imaging to Evaluate Breast Masses”, Korean Journal of Radiology: Official Journal of the Korean Radiological Society, 21(9): 1045-1054 (Jan. 2020). |
Lehman, CD, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356:1295-1303. |
Lewin, JM, et al., Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology 2003; 229:261-268. |
Lilja, Mikko, “Fast and accurate voxel projection technique in free-form cone-beam geometry with application to algebraic reconstruction,” Applies Sciences on Biomedical and Communication Technologies, 2008, Isabel '08, first international symposium on, IEEE, Piscataway, NJ, Oct. 25, 2008. |
Lindfors, KK, et al., Dedicated breast CT: initial clinical experience. Radiology 2008; 246(3): 725-733. |
Love, Susan M., et al. “Anatomy of the nipple and breast ducts revisited”, Cancer, American Cancer Society, Philadelphia, PA, vol. 101, No. 9, Sep. 20, 2004, pp. 1947-1957. |
Mahesh, Mahadevappa, “AAPM/RSNA Physics Tutorial for Residents—Digital Mammography: An Overview”, Nov.-Dec. 2004, vol. 24, No. 6, 1747-1760. |
Metheany, Kathrine G. et al., “Characterizing anatomical variability in breast CT images”, Oct. 2008, Med. Phys. 35 (10); 4685-4694. |
Niklason, L., et al., Digital tomosynthesis in breast imaging. Radiology. Nov. 1997; 205(2):399-406. |
Nikunjc, Oza et al., Dietterich, T.G., Ed., “Ensemble methods in machine learning”, Jan. 1, 2005, Multiple Classifier Systems, Lecture Notes in Computer Science; LNCS, Springer-Verlag Berlin/Heidelberg, pp. 1-15, abstract. |
Pathmanathan et al., “Predicting tumour location by simulating large deformations of the breast using a 3D finite element model and nonlinear elasticity”, Medical Image Computing and Computer-Assisted Intervention, pp. 217-224, vol. 3217 (2004). |
Pediconi, “Color-coded automated signal intensity-curve for detection and characterization of breast lesions: Preliminary evaluation of new software for MR-based breast imaging,” International Congress Series 1281 (2005) 1081-1086. |
Poplack, SP, et al., Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. AJR Am J Roentgenology Sep. 2007 189(3):616-23. |
Prionas, ND, et al., Contrast-enhanced dedicated breast CT: initial clinical experience. Radiology. Sep. 2010 256(3):714-723. |
Rafferty, E. et al., “Assessing Radiologist Performance Using Combined Full-Field Digital Mammography and Breast Tomosynthesis Versus Full-Field Digital Mammography Alone: Results” presented at 2007 Radiological Society of North America meeting, Chicago IL. |
Reynolds, April, “Stereotactic Breast Biopsy: A Review”, Radiologic Technology, vol. 80, No. 5, Jun. 1, 2009, pp. 447M-464M, XP055790574. |
Sakic et al., “Mammogram synthesis using a 3D simulation. I. breast tissue model and image acquisition simulation” Medical Physics. 29, pp. 2131-2139 (2002). |
Samani, A. et al., “Biomechanical 3-D Finite Element Modeling of the Human Breast Using MRI Data”, 2001, IEEE Transactions on Medical Imaging, vol. 20, No. 4, pp. 271-279. |
Samulski, Maurice et al., “Optimizing case-based detection performance in a multiview CAD system for mammography”, IEEE Transactions on Medical Imaging, vol. 30, No. 4, Apr. 1, 2011, pp. 1001-1009, XP011352387, ISSN: 0278-0062, DOI: 10.1109/TMI.2011.2105886, abstract. |
Sechopoulos, et al., “Glandular radiation dose in tomosynthesis of the breast using tungsten targets”, Journal of Applied Clinical Medical Physics, vol. 8, No. 4, Fall 2008, 161-171. |
Shrading, Simone et al., “Digital Breast Tomosynthesis-guided Vacuum-assisted Breast Biopsy: Initial Experiences and Comparison with Prone Stereotactic Vacuum-assisted Biopsy”, the Department of Diagnostic and Interventional Radiology, Univ. of Aachen, Germany, published Nov. 12, 2014, 10 pgs. |
Smith, A., “Full field breast tomosynthesis”, Radiol Manage. Sep.-Oct. 2005; 27(5):25-31. |
Taghibakhsh, f. et al., “High dynamic range 2-TFT amplified pixel sensor architecture for digital mammography tomosynthesis”, IET Circuits Devices Syst., 2007, 1(10, pp. 87-92. |
Van Schie, Guido, et al., “Generating Synthetic Mammograms from Reconstructed Tomosynthesis Volumes”, IEEE Transactions on Medical Imaging, vol. 32, No. 12, Dec. 2013, 2322-2331. |
Van Schie, Guido, et al., “Mass detection in reconstructed digital breast tomosynthesis volumes with a computer-aided detection system trained on 2D mammograms”, Med. Phys. 40(4), Apr. 2013, 41902-1-41902-11. |
Varjonen, Mari, “Three-Dimensional Digital Breast Tomosynthesis in the Early Diagnosis and Detection of Breast Cancer”, IWDM 2006, LNCS 4046, 152-159. |
Weidner N, et al., “Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma”, New England Journal of Medicine 1991; 324:1-8. |
Weidner, N, “The importance of tumor angiogenesis: the evidence continues to grow”, AM J Clin Pathol. Nov. 2004 122(5):696-703. |
Wen, Junhai et al., “A study on truncated cone-beam sampling strategies for 3D mammography”, 2004, IEEE, 3200-3204. |
Williams, Mark B. et al., “Optimization of exposure parameters in full field digital mammography”, Medical Physics 35, 2414 (May 20, 2008); doi: 10.1118/1.2912177, pp. 2414-2423. |
Wodajo, Felasfa, MD, “Now Playing: Radiology Images from Your Hospital PACS on your iPad,” Mar. 17, 2010; web site: http://www.imedicalapps.com/2010/03/now-playing-radiology-images-from-your-hospital-pacs-on-your-ipad/, accessed on Nov. 3, 2011 (3 pages). |
Yin, H.M., et al., “Image Parser: a tool for finite element generation from three-dimensional medical images”, BioMedical Engineering Online. 3:31, pp. 1-9, Oct. 1, 2004. |
Zhang, Yiheng et al., “A comparative study of limited-angle cone-beam reconstruction methods for breast tomosythesis”, Med Phys., Oct. 2006, 33(10): 3781-3795. |
Zhao, Bo, et al., “Imaging performance of an amorphous selenium digital mammography detector in a breast tomosynthesis system”, May 2008, Med. Phys 35(5); 1978-1987. |
Number | Date | Country | |
---|---|---|---|
20240320827 A1 | Sep 2024 | US |
Number | Date | Country | |
---|---|---|---|
63283866 | Nov 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2022/080432 | Nov 2022 | WO |
Child | 18671250 | US |